Kintz Samuel
Insider CIK 1967168 · ELVN President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-11-17 | 2025-11-19 | 12,500 | $21.82 | $272.8K | 890,392 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-10-17 | 2025-10-21 | 12,500 | $21.33 | $266.6K | 902,892 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-09-26 | 2025-09-30 | 3,700 | $20.06 | $74.2K | 915,392 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-09-23 | 2025-09-25 | 2,800 | $20.03 | $56.1K | 919,092 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-09-19 | 2025-09-19 | 1,000 | $20.25 | $20.3K | 921,892 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-09-17 | 2025-09-19 | 5,000 | $19.09 | $95.5K | 922,892 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-08-20 | 2025-08-21 | 1,517 | $20.00 | $30.3K | 927,892 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-08-19 | 2025-08-20 | 590 | $20.00 | $11.8K | 929,409 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-08-18 | 2025-08-20 | 10,393 | $20.02 | $208.1K | 929,999 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-07-17 | 2025-07-21 | 3,663 | $23.37 | $85.6K | 940,392 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-07-17 | 2025-07-21 | 4,687 | $22.69 | $106.3K | 944,055 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-07-17 | 2025-07-21 | 4,150 | $21.58 | $89.6K | 948,742 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-06-17 | 2025-06-18 | 1,998 | $22.75 | $45.5K | 952,892 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-06-17 | 2025-06-18 | 10,502 | $22.08 | $231.9K | 954,890 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-06-03 | 2025-06-05 | 7,500 | $20.05 | $150.4K | 965,392 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-05-19 | 2025-05-21 | 5,000 | $16.49 | $82.4K | 972,892 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-05-02 | 2025-05-05 | 2,170 | $20.00 | $43.4K | 977,892 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-05-01 | 2025-05-05 | 5,330 | $20.08 | $107.0K | 980,062 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-04-17 | 2025-04-21 | 5,000 | $16.42 | $82.1K | 985,392 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2025-03-17 | 2025-03-19 | 12,500 | $20.83 | $260.4K | 990,392 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2025-02-06 | 2025-02-10 | 490,000 | — | $0 | 490,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-18 | 2024-10-22 | 924 | $30.00 | $27.7K | 1,002,892 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-09 | 2024-10-10 | 13,880 | $28.07 | $389.6K | 1,006,646 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-09 | 2024-10-10 | 2,830 | $28.53 | $80.7K | 1,003,816 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-08 | 2024-10-10 | 13,167 | $27.95 | $368.0K | 1,020,626 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-08 | 2024-10-10 | 100 | $28.51 | $2.9K | 1,020,526 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-07 | 2024-10-08 | 2,730 | $27.50 | $75.1K | 1,033,793 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-04 | 2024-10-08 | 12,206 | $27.51 | $335.8K | 1,036,523 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 526 | $27.54 | $14.5K | 1,048,729 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-08-26 | 2024-08-28 | 12,000 | $22.89 | $274.7K | 1,049,255 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-31 | 2024-08-02 | 2,270 | $27.56 | $62.6K | 1,061,255 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-25 | 2024-07-29 | 43 | $25.83 | $1.1K | 1,063,525 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-25 | 2024-07-29 | 8,164 | $25.10 | $204.9K | 1,063,568 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-07-25 | 2024-07-29 | 3,793 | $24.53 | $93.0K | 1,071,732 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-06-25 | 2024-06-27 | 11,422 | $21.63 | $247.1K | 1,076,103 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-06-25 | 2024-06-27 | 578 | $22.30 | $12.9K | 1,075,525 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-05-28 | 2024-05-30 | 12,000 | — | $0 | 188,841 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-28 | 2024-05-30 | 100 | $24.34 | $2.4K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-28 | 2024-05-30 | 5,219 | $23.57 | $123.0K | 100 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-05-28 | 2024-05-30 | 6,681 | $22.86 | $152.7K | 5,319 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-05-28 | 2024-05-30 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-04-25 | 2024-04-29 | 12,000 | — | $0 | 200,841 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-04-25 | 2024-04-29 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-25 | 2024-04-29 | 12,000 | $16.89 | $202.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-04-11 | 2024-04-15 | 47,709 | — | $0 | 212,841 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-04-11 | 2024-04-15 | 47,709 | $25.04 | $1.19M | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-04-11 | 2024-04-15 | 47,709 | $1.12 | $53.4K | 47,709 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-03-25 | 2024-03-27 | 12,000 | — | $0 | 260,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-03-25 | 2024-03-27 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-03-25 | 2024-03-27 | 4,671 | $18.16 | $84.8K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-03-25 | 2024-03-27 | 7,329 | $17.17 | $125.8K | 4,671 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-02-26 | 2024-02-28 | 12,000 | — | $0 | 272,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-02-26 | 2024-02-28 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 7,624 | $16.69 | $127.2K | 4,376 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-02-26 | 2024-02-28 | 4,376 | $17.24 | $75.4K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 410,000 | — | $0 | 410,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2024-01-25 | 2024-01-29 | 12,000 | — | $0 | 284,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-25 | 2024-01-29 | 9,458 | $15.89 | $150.3K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2024-01-25 | 2024-01-29 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2024-01-25 | 2024-01-29 | 2,542 | $14.94 | $38.0K | 9,458 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-26 | 2023-12-28 | 12,000 | — | $0 | 296,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-26 | 2023-12-28 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-26 | 2023-12-28 | 12,000 | $14.64 | $175.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-22 | 2023-12-26 | 8,175 | — | $0 | 308,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-22 | 2023-12-26 | 8,175 | $1.12 | $9.2K | 8,175 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-22 | 2023-12-26 | 8,175 | $13.05 | $106.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-21 | 2023-12-26 | 20 | — | $0 | 316,725 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-21 | 2023-12-26 | 20 | $13.00 | $260 | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-21 | 2023-12-26 | 20 | $1.12 | $22 | 20 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-12-20 | 2023-12-21 | 7,779 | — | $0 | 316,745 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-12-20 | 2023-12-21 | 7,779 | $1.12 | $8.7K | 7,779 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-12-20 | 2023-12-21 | 7,779 | $13.01 | $101.2K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-11-03 | 2023-11-06 | 8,026 | — | $0 | 324,524 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-11-03 | 2023-11-06 | 8,026 | $1.12 | $9.0K | 8,026 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-11-03 | 2023-11-06 | 8,026 | $13.08 | $105.0K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise deriv | 2023-09-25 | 2023-09-26 | 12,000 | — | $0 | 332,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | M Exercise | 2023-09-25 | 2023-09-26 | 12,000 | $1.12 | $13.4K | 12,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | S Sale | 2023-09-25 | 2023-09-26 | 12,000 | $13.81 | $165.7K | 0 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-04-04 | 2023-04-06 | 452,000 | — | $0 | 452,000 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 344,550 | — | $0 | 344,550 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award deriv | 2023-02-23 | 2023-02-27 | 404,363 | — | $0 | 404,363 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 1,087,525 | — | $0 | 1,087,525 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 88,531 | — | $0 | 88,531 | SEC↗ |
| ELVN Enliven Therapeutics, Inc. | A Award | 2023-02-23 | 2023-02-27 | 88,531 | — | $0 | 88,531 | SEC↗ |